Arvind Chopra

TL;DR: A larger population study is required to describe post-CHIKV rheumatism and its prognosis, as well as normal blood cell counts, elevated acute-phase reactants, and serum IL-6 often remained elevated in chronic cases.

TL;DR: In this Invited Commentary, a long-time JACM Editorial Board member Bhushan Patwardhan, PhD, from the AYUSH Center of Excellence, Center for Complementary and Integrative Health at the Savitribai Phule Pune University, India and colleagues from multiple institutions make a case for the potential roles of Ayurvedic medicine and Yoga as supportive measures in self-care and treatment.

TL;DR: This controlled drug trial demonstrates the potential efficacy and safety of RA- 11 in the symptomatic treatment of OA knees over 32 weeks of therapy.

TL;DR: While similar in spectrum, standardized prevalence rates of self-reported pain sites and rheumatic MSK disorders were significantly lower in the urban (current Pune COPCORD surveys) versus rural (Bhigwan) community, and in both communities aches and pains that are poorly understood by modern science were predominant.

TL;DR: It is demonstrated that RMS, although a predominant ailment, has a modest effect on daily living in most subjects with RMS; there is inconsistency between the measures of pain and disability (using HAQ) and their effects; and the beliefs and expectations of the community are described.